Want to see IN:JAGSNPHARM full AI Analyst Report?
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Revenue
Jagsonpal Pharmaceuticals Ltd. Revenue
Jagsonpal Pharmaceuticals Ltd. had a revenue of 822.32M in the quarter ending Jun 30, 2026, with 28.08%. This bring the company's revenue in the last twelve months to 2.94B, Increased 2.30%. In the fiscal year ending Mar 31, 2026, Jagsonpal Pharmaceuticals Ltd. had annual revenue of 2.87B with 6.89% growth.
- Revenue (ttm)
- 2.94B
- Revenue Growth
- 11.71%
- P/S Ratio
- 4.99
- Revenue/Employee
- INR 2,214,534
- Employees
- 1,297
- Market Cap
- INR 14.33B
Revenue Chart
Jagsonpal Pharmaceuticals Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.87B | 185.09M | 6.89% |
| Mar 31, 2025 | 2.69B | 600.14M | 28.76% |
| Mar 31, 2024 | 2.09B | -280.12M | -11.83% |
| Mar 31, 2023 | 2.37B | 191.30M | 8.79% |
| Mar 31, 2022 | 2.18B | 297.08M | 15.81% |
| Mar 31, 2021 | 1.88B | 293.08M | 18.48% |
| Mar 31, 2020 | 1.59B | -82.58M | -4.95% |
| Mar 31, 2019 | 1.67B | 402.93M | 31.84% |
| Mar 31, 2018 | 1.27B | -173.38M | -12.05% |
| Mar 31, 2017 | 1.44B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:JAGSNPHARM | 2.94B |
| IN:INDSWFTLAB | 6.65B |
| IN:LINCOLN | 7.19B |
| IN:SAKAR | 3.02B |
| IN:SYNCOMF | 4.98B |
| IN:VENUSREM | 8.11B |